Investor Relations | Aerie Pharmaceuticals, Inc
Aerie
Aerie Pharmaceuticals – Capital Sign Solutions
Aerie Pharmaceuticals Inc (AERI) Q3 2020 Earnings Call Transcript
Aerie Pharma on go with mid-stage study of eye drop for dry eye (NASDAQ:AERI) | Seeking Alpha
Aerie Pharma (AERI) Provides 2020 Company and Guidance Update Associated with COVID-19
Aerie Pharmaceuticals to Present at Two Investor Conferences in March | Business Wire
Eye disease drug firm Aerie Pharma acquires Spanish company for $10M | WRAL TechWire
Aerie Pharma appoints Richard Rubino as CFO | Procurement & Supply Chain | Healthcare Global
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Durham's Aerie Pharma raises $316.5M, to use funds for eye disease drug development | WRAL TechWire
Rise in the sentiment of investors in Aerie Pharmaceuticals INC. – Medgazette 24
Aerie-Pharma -
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Program
SEC Filings | Aerie Pharmaceuticals, Inc
Aerie Pharma: Finding Value In The Ophthalmic Space (NASDAQ:AERI) | Seeking Alpha
Aerie Pharmaceuticals Inc - AnnualReports.com
Cantor Initiates Aerie Pharma At Buy: 'Wouldn't Be Surprised If Aerie Became Takeover Candidate'
Aerie Pharmaceuticals and Ramot at Tel Aviv University Enter Research Collaboration | Business Wire
AERIE PHARMACEUTICALS, INC. : AERI Stock Price | MarketScreener
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
FDA OK of Aerie Pharma glaucoma drug jeopardized by factory issues out of its control
Aerie Pharma (AERI) Falls on Glaucoma Eye Drop Safety Concerns - TheStreet
Durham-based Aerie Pharma sees positive study results for eye pressure drug | WRAL TechWire
Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals Launches GMP Facility - Contract Pharma
Aerie-Pharma-Newsletter | OIS
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Compliance Program | Aerie Pharmaceuticals, Inc.
